152 related articles for article (PubMed ID: 29571993)
61. Randomized phase I study of standard-fractionated or accelerated-hyperfractionated radiotherapy with concurrent cisplatin and vindesine for unresectable non-small cell lung cancer: a report of Japan Clinical Oncology Group Study (JCOG 9601).
Tsuchiya S; Ohe Y; Sugiura T; Fuwa N; Kitamoto Y; Mori K; Kobayashi H; Nakata K; Sawa T; Hirai K; Etoh T; Saka H; Saito A; Fukuda H; Ishizuka N; Saijo N;
Jpn J Clin Oncol; 2001 Oct; 31(10):488-94. PubMed ID: 11696618
[TBL] [Abstract][Full Text] [Related]
62. Induction chemotherapy followed by concurrent chemotherapy and definitive high-dose radiotherapy for patients with locally advanced non-small-cell lung cancer (stages IIIa/IIIb): a pilot phase I/II trial.
Pöttgen C; Eberhardt W; Bildat S; Stüben G; Stamatis G; Hillejan L; Sohrab S; Teschler H; Seeber S; Sack H; Stuschke M
Ann Oncol; 2002 Mar; 13(3):403-11. PubMed ID: 11996471
[TBL] [Abstract][Full Text] [Related]
63. Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: phase II Southwest Oncology Group Study S9504.
Gandara DR; Chansky K; Albain KS; Leigh BR; Gaspar LE; Lara PN; Burris H; Gumerlock P; Kuebler JP; Bearden JD; Crowley J; Livingston R;
J Clin Oncol; 2003 May; 21(10):2004-10. PubMed ID: 12743155
[TBL] [Abstract][Full Text] [Related]
64. Concurrent chemoradiotherapy with cisplatin and vinorelbine for stage III non-small cell lung cancer.
Naito Y; Kubota K; Nihei K; Fujii T; Yoh K; Niho S; Goto K; Ohmatsu H; Saijo N; Nishiwaki Y
J Thorac Oncol; 2008 Jun; 3(6):617-22. PubMed ID: 18520801
[TBL] [Abstract][Full Text] [Related]
65. Induction chemotherapy plus high-dose radiotherapy versus radiotherapy alone in locally advanced unresectable non-small-cell lung cancer.
Crinò L; Latini P; Meacci M; Corgna E; Maranzano E; Darwish S; Minotti V; Santucci A; Tonato M
Ann Oncol; 1993 Dec; 4(10):847-51. PubMed ID: 8117604
[TBL] [Abstract][Full Text] [Related]
66. Concurrent cisplatin, etoposide, and radiotherapy for unresectable stage III nonsmall cell lung cancer: a phase II study.
Reboul F; Brewer Y; Vincent P; Chauvet B; Faure CF; Taulelle M
Int J Radiat Oncol Biol Phys; 1996 May; 35(2):343-50. PubMed ID: 8635942
[TBL] [Abstract][Full Text] [Related]
67. Final overall results of a study with a novel triplet induction chemotherapy regimen (PACCAGE) followed by consolidation radiotherapy in locally advanced inoperable non-small cell lung cancer (NSCLC).
Schallier D; Bral S; Ilsen B; Neyns B; Fontaine C; Decoster L; De Mey J; Meysman M; De Grève J
J Thorac Oncol; 2009 Jun; 4(6):728-35. PubMed ID: 19404217
[TBL] [Abstract][Full Text] [Related]
68. Radical radiotherapy or chemoradiotherapy for inoperable, locally advanced, non-small cell lung cancer: Analysis of patient profile, treatment approaches, and outcomes for 213 patients at a tertiary cancer center.
Shrimali RK; Nallathambi C; Saha A; Das A; Prasath S; Mahata A; Arun B; Mallick I; Achari R; Dabkara D; Thambudorai R; Chatterjee S
Indian J Cancer; 2018; 55(2):125-133. PubMed ID: 30604722
[TBL] [Abstract][Full Text] [Related]
69. Phase II study of bi-weekly docetaxel and carboplatin with concurrent thoracic radiation therapy followed by consolidation chemotherapy with docetaxel plus carboplatin for stage III unresectable non-small cell lung cancer.
Sakai H; Yoneda S; Kobayashi K; Komagata H; Kosaihira S; Kazumoto T; Saito Y
Lung Cancer; 2004 Feb; 43(2):195-201. PubMed ID: 14739040
[TBL] [Abstract][Full Text] [Related]
70. Effect of durvalumab on local control after concurrent chemoradiotherapy for locally advanced non-small cell lung cancer in comparison with chemoradiotherapy alone.
Abe T; Saito S; Iino M; Aoshika T; Ryuno Y; Ohta T; Igari M; Hirai R; Kumazaki Y; Miura Y; Kaira K; Kagamu H; Noda SE; Kato S
Thorac Cancer; 2021 Jan; 12(2):245-250. PubMed ID: 33289347
[TBL] [Abstract][Full Text] [Related]
71. Novel approaches of chemoradiotherapy in unresectable stage IIIA and stage IIIB non-small cell lung cancer.
Stinchcombe TE; Bogart JA
Oncologist; 2012; 17(5):682-93. PubMed ID: 22531360
[TBL] [Abstract][Full Text] [Related]
72. Radiotherapy for inoperable non-small cell lung cancer using helical tomotherapy.
Monaco A; Caruso C; Giammarino D; Cianciulli M; Pressello MC; Donato V
Tumori; 2012; 98(1):86-9. PubMed ID: 22495706
[TBL] [Abstract][Full Text] [Related]
73. Concurrent low-dose cisplatin and thoracic radiotherapy in patients with inoperable stage III non-small cell lung cancer: a phase II trial with special reference to the hemoglobin level as prognostic parameter.
Pradier O; Lederer K; Hille A; Weiss E; Christiansen H; Schmidberger H; Hess CF
J Cancer Res Clin Oncol; 2005 Apr; 131(4):261-9. PubMed ID: 15616830
[TBL] [Abstract][Full Text] [Related]
74. Induction chemotherapy and continuous hyperfractionated accelerated radiotherapy (chart) for patients with locally advanced inoperable non-small-cell lung cancer: the MRC INCH randomized trial.
Hatton M; Nankivell M; Lyn E; Falk S; Pugh C; Navani N; Stephens R; Parmar M
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):712-8. PubMed ID: 20932667
[TBL] [Abstract][Full Text] [Related]
75. Oral vinorelbine and cisplatin with concomitant radiotherapy in stage III non-small cell lung cancer (NSCLC): a feasibility study.
Beckmann G; Fietkau R; Huber RM; Kleine P; Schmidt M; Semrau S; Aubert D; Fittipaldo A; Flentje M
Onkologie; 2006 Apr; 29(4):137-42. PubMed ID: 16601369
[TBL] [Abstract][Full Text] [Related]
76. Does response to induction chemotherapy predict survival for locally advanced non-small-cell lung cancer? Secondary analysis of RTOG 8804/8808.
McAleer MF; Moughan J; Byhardt RW; Cox JD; Sause WT; Komaki R
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):802-8. PubMed ID: 19540055
[TBL] [Abstract][Full Text] [Related]
77. A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer.
Argiris A; Liptay M; LaCombe M; Marymont M; Kies MS; Sundaresan S; Masters G
Lung Cancer; 2004 Aug; 45(2):243-53. PubMed ID: 15246197
[TBL] [Abstract][Full Text] [Related]
78. Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105.
Socinski MA; Blackstock AW; Bogart JA; Wang X; Munley M; Rosenman J; Gu L; Masters GA; Ungaro P; Sleeper A; Green M; Miller AA; Vokes EE
J Clin Oncol; 2008 May; 26(15):2457-63. PubMed ID: 18487565
[TBL] [Abstract][Full Text] [Related]
79. Results of multifield conformal radiation therapy of nonsmall-cell lung carcinoma using multileaf collimation beams.
Bahri S; Flickinger JC; Kalend AM; Deutsch M; Belani CP; Sciurba FC; Luketich JD; Greenberger JS
Radiat Oncol Investig; 1999; 7(5):297-308. PubMed ID: 10580899
[TBL] [Abstract][Full Text] [Related]
80. A phase I study of gefitinib with concurrent dose-escalated weekly docetaxel and conformal three-dimensional thoracic radiation followed by consolidative docetaxel and maintenance gefitinib for patients with stage III non-small cell lung cancer.
Center B; Petty WJ; Ayala D; Hinson WH; Lovato J; Capellari J; Oaks T; Miller AA; Blackstock AW
J Thorac Oncol; 2010 Jan; 5(1):69-74. PubMed ID: 20035186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]